Allergan's SkinMedica Tackles Blue Light and More with New LUMIVIVE System

Thursday, September 06, 2018 | Skin Care , Product Launches and Updates , Allergan , SkinMedica


Allergan is launching the SkinMedica LUMIVIVE System, with two distinct formulas - one to shield skin from blue light and environmental aggressors during the day and another to recharge the skin's repair process at night for 24-hour protection and revitalization.

"Skin today is under attack from multiple invisible threats," says San Diego-based dermatologist Sabrina Fabi, MD, in a news release. "Visible light,  including blue light like that emitted by phones and devices, is particularly insidious, because it penetrates deeper than some forms of ultraviolet light,  down into the third layer of the skin,  accelerating the visible signs of aging, such as dark spots, wrinkles, and saggy or loose skin.”

In clinical studies conducted in some of the most polluted cities in the world, LUMIVIVE improved the appearance of skin tone, evenness and restored stressed skin for a more luminous complexion. Fully 85 percent of patients agreed that LUMIVIVE reduced the effects of environmental damage on their skin and kept their skin looking radiant throughout the day.

"People around the world, spend an average of two hours per day on social media, while the average American looks at their phone 47 times a day and spends about ten hours a day in front of a screen," says Carrie Strom, Senior Vice President, U.S. Medical Aesthetics at Allergan. "We know that blue light and pollution are all around us and can't be avoided.  We felt it was important to address an unmet need by creating a system that not only protects the skin from environmental damage during the day, but also enhances the skin's ability to restore and repair skin during the sleep-repair cycle as well."

SkinMedica LUMIVIVE System is available through a network of licensed healthcare providers; please visit skinmedica.com for locations.

 

Next Story

Comments

You must be logged in to leave a comment.